ANGO vs EFX · rev $292.5M vs P/E 54, rev $5.68B
AngioDynamics Inc (ANGO) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
ANGO currently screens at market cap $378.5M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the ANGO and EFX stock pages for the full models.
Not investment advice.